Sort
21,453 grants matching “tuberculosis”
Virulence Factors in Mycobacteria
$364,050Harvard University (Sch Of Public Hlth) · R01 · FY2005 · AI
Virulence Factors in Mycobacteria
$364,050Harvard University (Sch Of Public Hlth) · R01 · FY2004 · AI
Virulence Factors in Mycobacteria
$364,050Harvard University (Sch Of Public Hlth) · R01 · FY2003 · AI
Virulence Factors in Mycobacteria
$364,050Harvard University (Sch Of Public Hlth) · R01 · FY2002 · AI
Control of cell wall synthesis and antibiotic tolerance in mycobacteria
$364,032Cara Cheney Boutte · University Of Texas Arlington · R01 · FY2024 · AI
Center for Humanized Mice
$363,960Larisa Y Poluektova · University Of Nebraska Medical Center · R24 · FY2017 · OD
The role of polyphosphate and acidocalcisomes in Trypanosoma brucei
$363,862Roberto Docampo · University Of Georgia · R01 · FY2011 · AI
M. tuberculosis Genes Regulating Persistent Infection
$363,851Thomas C. Zahrt · Medical College Of Wisconsin · R01 · FY2007 · AI
Mode of Action of Thiorcarlide in Mycobacterium Tuberculosis
$363,825Mary Jackson · Colorado State University · R01 · FY2010 · AI
Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
$363,756John Lucian Davis · Yale University · R01 · FY2025 · HL
Discovery of Novel Nontuberculous Inhibitors
$363,750Elton Jeffrey North · Creighton University · R15 · FY2021 · AI
M. tuberculosis defenses against host oxidant systems.
$363,746Vojo P Deretic · University Of New Mexico · R01 · FY2006 · AI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors
$363,738Thomas C. Terwilliger · Texas A&M University · U01 · FY2010 · GM
400 MHz NMR Spectrometer for Shared Use
$363,713Johns Hopkins University · S10 · FY2004 · RR
Pathogenesis of Cryptococcus Spores
$363,696Christina M Hull · University Of Wisconsin-Madison · R01 · FY2012 · AI
Pathogenesis of Cryptococcus Spores
$363,696Christina M Hull · University Of Wisconsin-Madison · R01 · FY2011 · AI
Type III Polyketide Synthases: Structure and Mechanism
$363,646University Of Arizona · R01 · FY2002 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$363,644Dorothy Danfels Deputy · New Mexico State Department Of Health · U52 · FY2008 · PS
Novel immune-based therapy for leishmaniasis and tuberculosis
$363,483Christopher L Karp · Newlink Genetics Corporation · R41 · FY2009 · AI
Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness.
$363,472Jonathan E Golub · Johns Hopkins University · U01 · FY2025 · CA
Antibody Protection in Histoplamosis
$363,442Joshua D Nosanchuk · Albert Einstein College Of Medicine · R01 · FY2006 · AI
Antigen exposure in utero: impacts on newborn immunity and infectious diseases
$363,322Cristiana Cairo · University Of Maryland Baltimore · R01 · FY2013 · AI
Structural And Biochemical Characterization Of A Novel Mycobacterial Heme Uptake
$363,287Celia Goulding · University Of California-Irvine · R01 · FY2009 · AI
Disrupting Biofilm Formation to Improve TB Drug Treatment
$363,261Randall J Basaraba · Colorado State University · R01 · FY2017 · AI
Disrupting Biofilm Formation to Improve TB Drug Treatment
$363,261Randall J Basaraba · Colorado State University · R01 · FY2014 · AI